Foghorn Therapeutics Appoints Ryan Maynard as CFO
Foghorn Therapeutics announced that Ryan Maynard will join the company as Chief Financial Officer, CFO, on February 23, 2026. Maynard joins Foghorn with over 25 years of executive experience driving financial strategy, capital markets execution, and operational performance across public and private biopharmaceutical companies. Prior to joining Foghorn, Maynard was most recently at Cara Therapeutics
